Obesity

Understanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.

Tirzepatide, a novel once-weekly GLP-1/GIP mimetic that binds to receptors and stimulates glucose-dependent insulin release, has shown superiority over many common antihyperglycemics.

The Canadian Obesity Society advocates for a therapeutic approach to obesity that removes stigma, focuses on individual patient goals, and favors body health over body weight.

Women, Black individuals, and adults diagnosed with overweight or obesity in more recent years were more likely to receive a referral, according to new study.

The proportion of overweight, obesity, or severe obesity increased from 38% to 45% among 4500 young people seen in a primary care network where most receive public insurance.

Obesity requires a spectrum of treatment options for effective results. Here, 3 key points to keep in mind when considering antiobesity medication for patients.

The observational study found that longer duration of disease conferred a 32% greater risk of obesity and that nonatopic asthma carried at 47% greater risk.

Tirzepatide was associated with reductions in body weight of up to 22.5% over 72 weeks in the global phase 3 registration trial.

Asthma-COPD overlap and obesity mutually exacerbate each other and an early program of pulmonary rehabilitation shows promise to help both.

Obesity significantly increased the risk of heart failure among women who experienced menopause at age ≥55 years in a new study.

Persons with type 2 diabetes who either gained or lost 5% of baseline bodyweight were found to be at higher risk for heart failure, MI, and all-cause death.

Having overweight or obesity in midlife was associated with significantly higher cumulative morbidity and health care costs during older adulthood in prospective cohort study.

An overview of common and uncommon obesity-related comorbidities and treatment strategies, here.

Nearly two-thirds of persons aged younger than 50 years who had an acute ischemic stroke had obesity in a study presented at the 2022 International Stroke Conference.

How do low socioeconomic status and adverse childhood experiences tie into pediatric obesity? Here, an overview for practitioners.

Three diets that can help patients with obesity age healthier, how to make nutrition personal, and more highlighted, here.

The highest percentage of youth without a high school diploma is in New Mexico and the youth poverty rate is highest in DC. More red flag indicators follow.

Coronary heart disease prevalence in the US between 2011 and 2018 saw a statistically insignificant change, from 6.2% to 6.0%, respectively.

Using Mendelian randomization, a new study found in particular that waist-hip ratio may be a more important predictor of hospitalization than BMI.

Take this quick quiz to test your knowledge of recent advances most likely to have an impact on weight management in your practice.

Among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of severe COVID-19, suggests new research.

Increases in obesity parameters significantly increased risk of incident heart failure in persons with diabetes, but not without diabetes, in a large community-based cohort study.

The Guideline Toplines slide-show feature offers busy primary care physicians at-a-glance summaries of new and updated clinical guidelines across therapeutic areas.

Find out how effective each of 8 ACC/AHA-recommended non-drug interventions is at reducing BP (in mm Hg) in adults with hypertension and normal BP.

Obesity and its causes are the focus of extensive research evaluating new therapeutic targets. Get an at-a-glance update on progress and FDA approvals during 2021

In patients with biopsy-proven NASH, the SPLENDOR study is the first to report a medical modality associated with decreased risk of major adverse events.

Weight bias themes in primary care are the subject of contemporary research. Which options you choose to these 8 questions may offer insight into your own unconscious prejudices.

Weight bias or stigma in healthcare settings, whether explicit or implicit, may keep patients from getting care. Find a review of the recent literature in this slide show.

Semaglutide 2.4 mg led to clinically significant weight loss and improvements in cardiometabolic risk factors in adults with moderate or severe obesity, suggests new research from ObesityWeek 2021.

Recognizing obesity as chronic pathophysiologic dysfunction and explaining that to a patient will make them remarkably more receptive to all other discussions about treatment, says obesity specialist Kaplan.